Scholar Rock Holding Corporation

SRRK

$55.94

-0.29%-$0.16

High—

Low—

52W High-9.4%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

AI analysis

Scholar Rock Holding Corporation is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$55.89

5-period simple moving average

SMA10

$55.60

10-period simple moving average

SMA20

$55.49

20-period simple moving average

SMA50

$55.62

50-period simple moving average

EMA5

$55.86

5-period exponential moving average

EMA10

$55.71

10-period exponential moving average

EMA20

$55.60

20-period exponential moving average

DEMA20

$55.67

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$55.81

Volume weighted average price

MACD

0.080

Signal -0.014

RSI(14)

82.2

Relative strength oscillator

OBV

-130.14K

On-balance volume

StochRSI

82.2 / 82.2

Fast oscillator pair

BBands Low

$54.97

Lower band

BBands Mid

$55.49

Middle band

BBands High

$56.01

Upper band

Market Cap

6.70B

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

-2.08

Enterprise value multiple

ROE

-167.8%

Return on equity

ROA

-58.8%

Return on assets

Operating Margin

0.0%

Operating efficiency

Net Margin

0.0%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

0.67

Market sensitivity

52W High

$61.76

52-week peak

52W Low

$27.07

52-week trough

Supply Chain of SRRK

Upstream / Downstream / Proxies

Upstream

Catalent Indiana LLC / Novo Nordisk (Bloomington, IN Fill-Finish Facility)NYSE:NVOSecond U.S.-Based Fill-Finish Facility (Undisclosed CDMO)Third-Party Drug Substance Manufacturer (Undisclosed CDMO)Thermo Fisher Scientific Inc.NYSE:TMOSartorius AGXETRA:SRTDanaher Corporation (Cytiva)NYSE:DHRMerck KGaA (MilliporeSigma)XETRA:MRKWest Pharmaceutical Services Inc.NYSE:WST Bio-Rad Laboratories Inc.NYSE:BIO

Downstream

Spinal Muscular Atrophy (SMA) Patients - U.S. MarketGilead Sciences Inc.NASDAQ:GILDSMA Treatment Centers (U.S. Academic & Hospital Centers)Specialty Pharmacy Distributors (U.S. - Undisclosed)

Proxies

Biogen Inc.NASDAQ:BIIB Sarepta Therapeutics Inc.NASDAQ:SRPT Novo Nordisk A/SNYSE:NVO Biohaven Ltd.NYSE:BHVN

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer